IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Joachim-Friedrich Kapp

USPTO Granted Patents = 9

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 82(Granted Patents)


Company Filing History:

goldMedal9 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1977-1984

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4457927 - Pyrido[2,1-b]quinazolinone derivatives and the preparation and use (1984-07-03),
2. 4407823 - Novel phenylacetic acid derivatives (1983-10-04),
3. 4296109 - Corticoid 21-sulfopropionates and the salts thereof, a process for the (1981-10-20),
4. 4289763 - Novel corticoids, the preparation thereof and the use thereof (1981-09-15),
5. 4244960 - Indanyl derivatives and their use (1981-01-13),
6. 4207316 - Novel 17-substituted 11 .beta.-hydroxy steroids of the pregnane series, (1980-06-10),
7. 4196203 - Novel corticoids (1980-04-01),
8. 4176126 - Novel corticoids (1979-11-27),
9. 4042706 - Novel anti-inflammatory pyrazole derivatives and preparation thereof (1977-08-16),

Title: The Innovative Contributions of Joachim-Friedrich Kapp

Introduction

Joachim-Friedrich Kapp is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. With a total of 9 patents to his name, Kapp's work has had a considerable impact on various applications in the pharmaceutical industry.

Latest Patents

Kapp's latest patents include innovative compounds such as Pyrido[2,1-b]quinazolinone derivatives. These derivatives are characterized by their unique formula, which includes various functional groups that enhance their physiological compatibility. Another significant patent involves novel phenylacetic acid derivatives, which are designed to exhibit specific chemical properties that can be utilized in medicinal chemistry.

Career Highlights

Throughout his career, Kapp has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work at Schering has allowed him to focus on research and development, leading to the creation of several important chemical compounds. His expertise in the field has positioned him as a key figure in the advancement of pharmaceutical innovations.

Collaborations

Kapp has collaborated with esteemed colleagues such as Henry Laurent and Rudolf Wiechert. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Joachim-Friedrich Kapp's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the pharmaceutical industry, showcasing the importance of research and collaboration in driving innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…